Vivoryon Therapeutics Nv【0R3M】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

4.71

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

4.71 52 週間の範囲 4.71

時価総額

前日終値

4.71

始値

時刻

2.02

(O)

最終取引時間

17:00:08

財務取引量

VWAP

平均取引量 (3 か月)

5,043

発行済株式数

0.00

配当利回り

PER

0.00

1 株当たり利益 (EPS)

歳入

-3.62M

純利益

-28.34M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.vivoryon.com

本社

Halle, Deu

設立

Vivoryon Therapeutics Nv is listed in the Biological Pds,ex Diagnstics sector of the ロンドン証券取引所 with ticker 0R3M. The last closing price for Vivoryon Therapeutics Nv was 4.71 €. Over the last year, Vivoryon Therapeutics Nv shares have traded in a share price range of 4.71 € to 4.71 €.

Vivoryon Therapeutics Nv currently has 0 shares in issue.

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

期間 †	始値	高値	安値	平均出来高	VWAP
1	4.71	4.71	4.71	3914	4.71	DE
4	4.71	4.71	4.71	8979	4.71	DE
12	4.71	4.71	4.71	5043	4.71	DE
26	4.71	4.71	4.71	9366	4.71	DE
52	4.71	4.71	4.71	12304	4.71	DE
156	4.71	4.71	4.71	5985	4.71	DE
260	4.71	4.71	4.71	4234	4.71	DE

0R3M - Frequently Asked Questions (FAQ)

What is the current Vivoryon Therapeutics Nv share price?

The current share price of Vivoryon Therapeutics Nv is 4.71 €

What is the 1 year trading range for Vivoryon Therapeutics Nv share price?

Vivoryon Therapeutics Nv has traded in the range of 4.71 € to 4.71 € during the past year

What is the reporting currency for Vivoryon Therapeutics Nv?

Vivoryon Therapeutics Nv reports financial results in EUR

What is the latest annual turnover for Vivoryon Therapeutics Nv?

The latest annual turnover of Vivoryon Therapeutics Nv is EUR -3.62M

What is the latest annual profit for Vivoryon Therapeutics Nv?

The latest annual profit of Vivoryon Therapeutics Nv is EUR -28.34M

What is the registered address of Vivoryon Therapeutics Nv?

The registered address for Vivoryon Therapeutics Nv is WEINBERGWEG 22, HALLE, 06120

What is the Vivoryon Therapeutics Nv website address?

The website address for Vivoryon Therapeutics Nv is www.vivoryon.com

Which industry sector does Vivoryon Therapeutics Nv operate in?

Vivoryon Therapeutics Nv operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
0A2IH World Group Ltd	US$ 0.00 (0.00%)	0
0A2DCrh Plc	US$ 0.00 (0.00%)	0
0A2BBanco Bilbao Vizcaya Argentaria Sa	US$ 0.00 (0.00%)	0
0A22Anheuser Busch Inbev Nv	US$ 0.00 (0.00%)	0
0A1UUber Technologies Inc	US$ 61.55 (0.00%)	782
0A2IH World Group Ltd	US$ 0.00 (0.00%)	0
0A2DCrh Plc	US$ 0.00 (0.00%)	0
0A2BBanco Bilbao Vizcaya Argentaria Sa	US$ 0.00 (0.00%)	0
0A22Anheuser Busch Inbev Nv	US$ 0.00 (0.00%)	0
0A1UUber Technologies Inc	US$ 61.55 (0.00%)	782
0HCIAlibaba Group Holding Ltd	US$ 86.10 (0.00%)	6.38k
0R0XTesla Inc	US$ 432.10 (0.00%)	5.29k
0A6LGamestop Corp	US$ 30.4075 (0.00%)	2.95k
0JOQJd.com Inc	US$ 72.00 (0.00%)	2.83k
0T3WBilibili Inc	US$ 0.00 (0.00%)	1.42k